Annual Current Liabilities
$16.78 M
-$82.03 M-83.02%
31 December 2023
Summary:
Ligand Pharmaceuticals Incorporated annual total current liabilities is currently $16.78 million, with the most recent change of -$82.03 million (-83.02%) on 31 December 2023. During the last 3 years, it has fallen by -$83.33 million (-83.24%). LGND annual current liabilities is now -92.97% below its all-time high of $238.87 million, reached on 31 December 2017.LGND Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$24.77 M
+$6.21 M+33.43%
30 September 2024
Summary:
Ligand Pharmaceuticals Incorporated quarterly total current liabilities is currently $24.77 million, with the most recent change of +$6.21 million (+33.43%) on 30 September 2024. Over the past year, it has increased by +$9.04 million (+57.51%). LGND quarterly current liabilities is now -96.88% below its all-time high of $793.34 million, reached on 30 September 2018.LGND Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LGND Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -83.0% | +57.5% |
| 3 y3 years | -83.2% | -31.8% |
| 5 y5 years | -79.6% | -30.6% |
LGND Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -83.2% | at low | -85.2% | +57.5% |
| 5 y | 5 years | -83.2% | at low | -85.2% | +57.5% |
| alltime | all time | -93.0% | +107.2% | -96.9% | +385.7% |
Ligand Pharmaceuticals Incorporated Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $24.77 M(+33.4%) |
| June 2024 | - | $18.57 M(+4.2%) |
| Mar 2024 | - | $17.82 M(+6.2%) |
| Dec 2023 | $16.78 M(-83.0%) | $16.78 M(+6.7%) |
| Sept 2023 | - | $15.73 M(-46.5%) |
| June 2023 | - | $29.39 M(-70.3%) |
| Mar 2023 | - | $98.93 M(+0.1%) |
| Dec 2022 | $98.81 M(+137.2%) | $98.81 M(-26.9%) |
| Sept 2022 | - | $135.24 M(-19.4%) |
| June 2022 | - | $167.85 M(+294.2%) |
| Mar 2022 | - | $42.58 M(+2.2%) |
| Dec 2021 | $41.66 M(-58.4%) | $41.66 M(+14.8%) |
| Sept 2021 | - | $36.30 M(-30.9%) |
| June 2021 | - | $52.50 M(-45.2%) |
| Mar 2021 | - | $95.81 M(-4.3%) |
| Dec 2020 | $100.11 M(+488.8%) | $100.11 M(+136.7%) |
| Sept 2020 | - | $42.30 M(+44.5%) |
| June 2020 | - | $29.26 M(+43.2%) |
| Mar 2020 | - | $20.44 M(+20.2%) |
| Dec 2019 | $17.00 M(-79.3%) | $17.00 M(-52.4%) |
| Sept 2019 | - | $35.70 M(-67.2%) |
| June 2019 | - | $108.98 M(-41.6%) |
| Mar 2019 | - | $186.78 M(+127.1%) |
| Dec 2018 | $82.25 M(-65.6%) | $82.25 M(-89.6%) |
| Sept 2018 | - | $793.34 M(+25.4%) |
| June 2018 | - | $632.85 M(+156.2%) |
| Mar 2018 | - | $246.98 M(+3.4%) |
| Dec 2017 | $238.87 M(+5.2%) | $238.87 M(+3.1%) |
| Sept 2017 | - | $231.68 M(+2.6%) |
| June 2017 | - | $225.84 M(-0.5%) |
| Mar 2017 | - | $227.00 M(-0.1%) |
| Dec 2016 | $227.13 M(+1.9%) | $227.13 M(+0.4%) |
| Sept 2016 | - | $226.13 M(+2.6%) |
| June 2016 | - | $220.35 M(+1700.2%) |
| Mar 2016 | - | $12.24 M(-94.5%) |
| Dec 2015 | $222.82 M(+878.2%) | $222.82 M(+1271.0%) |
| Sept 2015 | - | $16.25 M(-9.4%) |
| June 2015 | - | $17.95 M(-1.1%) |
| Mar 2015 | - | $18.16 M(-20.3%) |
| Dec 2014 | $22.78 M(-21.3%) | $22.78 M(+23.6%) |
| Sept 2014 | - | $18.43 M(-1.0%) |
| June 2014 | - | $18.62 M(-11.3%) |
| Mar 2014 | - | $21.00 M(-27.4%) |
| Dec 2013 | $28.94 M(-18.3%) | $28.94 M(-10.8%) |
| Sept 2013 | - | $32.46 M(-0.3%) |
| June 2013 | - | $32.57 M(-1.4%) |
| Mar 2013 | - | $33.02 M(-6.8%) |
| Dec 2012 | $35.44 M(-18.8%) | $35.44 M(+18.6%) |
| Sept 2012 | - | $29.88 M(-1.8%) |
| June 2012 | - | $30.42 M(+11.8%) |
| Mar 2012 | - | $27.21 M(-37.7%) |
| Dec 2011 | $43.64 M(+30.3%) | $43.64 M(+2.8%) |
| Sept 2011 | - | $42.45 M(+0.3%) |
| June 2011 | - | $42.31 M(-5.1%) |
| Mar 2011 | - | $44.57 M(+33.1%) |
| Dec 2010 | $33.49 M(-35.8%) | $33.49 M(-8.7%) |
| Sept 2010 | - | $36.68 M(-15.9%) |
| June 2010 | - | $43.60 M(+5.2%) |
| Mar 2010 | - | $41.43 M(-20.6%) |
| Dec 2009 | $52.17 M | $52.17 M(-1.6%) |
| Sept 2009 | - | $53.05 M(+10.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2009 | - | $48.20 M(-8.9%) |
| Mar 2009 | - | $52.88 M(-25.1%) |
| Dec 2008 | $70.61 M(+38.5%) | $70.61 M(+36.6%) |
| Sept 2008 | - | $51.70 M(+15.9%) |
| June 2008 | - | $44.61 M(+0.7%) |
| Mar 2008 | - | $44.31 M(-13.1%) |
| Dec 2007 | $50.97 M(-70.2%) | $50.97 M(-14.8%) |
| Sept 2007 | - | $59.83 M(-12.1%) |
| June 2007 | - | $68.06 M(-80.0%) |
| Mar 2007 | - | $340.50 M(+99.3%) |
| Dec 2006 | $170.81 M(-27.4%) | $170.81 M(-24.6%) |
| Sept 2006 | - | $226.41 M(-15.6%) |
| June 2006 | - | $268.41 M(+4.8%) |
| Mar 2006 | - | $256.03 M(+8.9%) |
| Dec 2005 | $235.21 M(+8.5%) | $235.21 M(+4.7%) |
| Sept 2005 | - | $224.59 M(+5.2%) |
| June 2005 | - | $213.48 M(-1.3%) |
| Mar 2005 | - | $216.22 M(-0.2%) |
| Dec 2004 | $216.71 M(+35.7%) | $216.71 M(+203.0%) |
| Sept 2004 | - | $71.53 M(+16.4%) |
| June 2004 | - | $61.47 M(+7.4%) |
| Mar 2004 | - | $57.26 M(-64.1%) |
| Dec 2003 | $159.71 M(+351.7%) | $159.71 M(+245.0%) |
| Sept 2003 | - | $46.29 M(+31.7%) |
| June 2003 | - | $35.15 M(-7.1%) |
| Mar 2003 | - | $37.82 M(+7.0%) |
| Dec 2002 | $35.35 M(+11.4%) | $35.35 M(+28.1%) |
| Sept 2002 | - | $27.61 M(-12.8%) |
| June 2002 | - | $31.68 M(-59.5%) |
| Mar 2002 | - | $78.31 M(+146.8%) |
| Dec 2001 | $31.73 M(+11.7%) | $31.73 M(+26.7%) |
| Sept 2001 | - | $25.03 M(-1.7%) |
| June 2001 | - | $25.45 M(+11.4%) |
| Mar 2001 | - | $22.85 M(-19.6%) |
| Dec 2000 | $28.41 M(+37.3%) | $28.41 M(+26.5%) |
| Sept 2000 | - | $22.45 M(-7.9%) |
| June 2000 | - | $24.38 M(+8.9%) |
| Mar 2000 | - | $22.39 M(+8.2%) |
| Dec 1999 | $20.70 M(-23.0%) | $20.70 M(+7.8%) |
| Sept 1999 | - | $19.20 M(-7.7%) |
| June 1999 | - | $20.80 M(+4.0%) |
| Mar 1999 | - | $20.00 M(-25.7%) |
| Dec 1998 | $26.90 M(+24.0%) | $26.90 M(+43.9%) |
| Sept 1998 | - | $18.70 M(-5.1%) |
| June 1998 | - | $19.70 M(+35.9%) |
| Mar 1998 | - | $14.50 M(-33.2%) |
| Dec 1997 | $21.70 M(+57.2%) | $21.70 M(+77.9%) |
| Sept 1997 | - | $12.20 M(-6.9%) |
| June 1997 | - | $13.10 M(+0.8%) |
| Mar 1997 | - | $13.00 M(-5.8%) |
| Dec 1996 | $13.80 M(-12.1%) | $13.80 M(+24.3%) |
| Sept 1996 | - | $11.10 M(-11.9%) |
| June 1996 | - | $12.60 M(-1.6%) |
| Mar 1996 | - | $12.80 M(-18.5%) |
| Dec 1995 | $15.70 M(+93.8%) | $15.70 M(+44.0%) |
| Sept 1995 | - | $10.90 M(+53.5%) |
| Mar 1995 | - | $7.10 M(-12.3%) |
| Dec 1994 | $8.10 M | $8.10 M(+14.1%) |
| Sept 1994 | - | $7.10 M(+39.2%) |
| June 1994 | - | $5.10 M(0.0%) |
| Mar 1994 | - | $5.10 M |
FAQ
- What is Ligand Pharmaceuticals Incorporated annual total current liabilities?
- What is the all time high annual current liabilities for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated annual current liabilities year-on-year change?
- What is Ligand Pharmaceuticals Incorporated quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated quarterly current liabilities year-on-year change?
What is Ligand Pharmaceuticals Incorporated annual total current liabilities?
The current annual current liabilities of LGND is $16.78 M
What is the all time high annual current liabilities for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high annual total current liabilities is $238.87 M
What is Ligand Pharmaceuticals Incorporated annual current liabilities year-on-year change?
Over the past year, LGND annual total current liabilities has changed by -$82.03 M (-83.02%)
What is Ligand Pharmaceuticals Incorporated quarterly total current liabilities?
The current quarterly current liabilities of LGND is $24.77 M
What is the all time high quarterly current liabilities for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high quarterly total current liabilities is $793.34 M
What is Ligand Pharmaceuticals Incorporated quarterly current liabilities year-on-year change?
Over the past year, LGND quarterly total current liabilities has changed by +$9.04 M (+57.51%)